COFG Advisors LLC Acquires New Position in iShares Biotechnology ETF $IBB

COFG Advisors LLC acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 22,616 shares of the financial services provider’s stock, valued at approximately $3,817,000. iShares Biotechnology ETF accounts for about 0.9% of COFG Advisors LLC’s investment portfolio, making the stock its 20th biggest position.

Other hedge funds have also recently modified their holdings of the company. Dynamic Wealth Strategies LLC boosted its stake in iShares Biotechnology ETF by 16.6% during the fourth quarter. Dynamic Wealth Strategies LLC now owns 422 shares of the financial services provider’s stock worth $71,000 after buying an additional 60 shares during the period. Flagship Private Wealth LLC boosted its stake in iShares Biotechnology ETF by 2.0% during the fourth quarter. Flagship Private Wealth LLC now owns 3,084 shares of the financial services provider’s stock worth $521,000 after buying an additional 60 shares during the period. Larson Financial Group LLC boosted its stake in iShares Biotechnology ETF by 2.3% during the fourth quarter. Larson Financial Group LLC now owns 2,717 shares of the financial services provider’s stock worth $458,000 after buying an additional 60 shares during the period. Webster Bank N. A. boosted its stake in iShares Biotechnology ETF by 1.0% during the fourth quarter. Webster Bank N. A. now owns 6,476 shares of the financial services provider’s stock worth $1,093,000 after buying an additional 62 shares during the period. Finally, Choreo LLC boosted its stake in iShares Biotechnology ETF by 2.2% during the fourth quarter. Choreo LLC now owns 3,043 shares of the financial services provider’s stock worth $514,000 after buying an additional 65 shares during the period. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 1.6%

Shares of IBB stock opened at $169.37 on Tuesday. The company has a 50-day moving average of $169.45 and a two-hundred day moving average of $170.45. iShares Biotechnology ETF has a 1-year low of $121.51 and a 1-year high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were issued a $0.1218 dividend. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a $0.49 annualized dividend and a yield of 0.3%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.